Sorry, you need to enable JavaScript to visit this website.

In certain clinical areas, a General Request for Proposal (RFP)* will be posted. The Request for Proposal (RFP) provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

Currently open General RFPs:

Geographic Scope Issue Date RFP Title

Submission Deadline

United States January 6, 2020Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM) April 1, 2020
United States January 6, 2020Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) October 30, 2020
United States January 23, 2020Astellas and Pfizer: Call for Independent Education Grants- Prostate Cancer March 19, 2020
Japan February 1, 2020Addressing Knowledge Gaps for the Appropriate Use of Biosimilars May 31, 2020
Japan February 4, 2020Preventing cardiovascular diseases such as venous thromboembolism in cancer patients by raising awareness and promoting medical cooperation June 30, 2020
United States and Canada February 10, 2020Targeted Therapy in Colorectal Cancer 13 Apr 2020
United States and Canada February 10, 2020MAPK inhibition in Melanoma 15 Apr 2020
United States February 12, 2020Ulcerative Colitis Patient Education March 27, 2020
Japan February 20, 2020Genetic counseling for hereditary transthyretin amyloidosis April 10, 2020
United States, Canada and Europe February 20, 2020 Patient Education in Chronic Myeloid Leukemia (CML) April 7, 2020
Japan March 3, 2020Employment support / Lung Cancer April 30, 2020
Japan March 3, 2020Biomarker Testing / Lung Cancer April 30, 2020
Africa, Asia (excluding Japan and Korea), Latin America and the Middle East March 5, 2020Knowledge Gaps in the Diagnosis and Management of Rheumatoid Arthritis (RA) in Africa, Asia, the Middle East and Latin America April 30, 2020
United States, Canada, Japan, Italy, UK, Spain, Germany, and/or France March 6, 2020Cachexia in Cancer April 29, 2020
North America: Canada, United States
Europe: France, Germany, Italy, Spain, Switzerland, United Kingdom
Latin America: Argentina
 March 9, 2020Immuno-therapy in Urothelial Carcinoma (UC) April 14, 2020
North America: Canada, United States
Europe: France, Germany, Italy, Spain, Switzerland, United Kingdom
Asia Pacific: Japan
Latin America: Brazil, Argentina
 March 9, 2020Therapy Management in Renal Cell Carcinoma (RCC) April 30, 2020
APAC/China Markets (Hong Kong, India, Indonesia, Malaysia, Pakistan,
Philippines, Singapore, Taiwan, Thailand, Vietnam)
 March 9, 2020Pfizer and RCNi – Providing Access to Learning Resources for Nurses in the APAC/China Region May 1, 2020
Japan March 11, 2020Addressing Knowledge Gaps in the Care of Patients with HR-positive/HER2-negative Advanced Breast Cancer May 31, 2020
Japan March 13, 2020Education relating to Etiology, diagnosis, treatment and, management of Spondyloarthritis July 30, 2020
Japan March 13, 2020Optimal treatment and management of Rheumatoid Arthritis July 30, 2020
Japan March 13, 2020Rheumatic diseases such as SLE, SS, SSc, vasculitis syndrome July 30, 2020
United States March 19, 2020Virtual Programs in Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists April 16, 2020

    To view previously posted RFPs that are now closed (i.e., applications no longer accepted) please click here.

    *formerly called CGAs (Call for Grant Applications) 

    Clinical Areas Reviewed through Joint Alliances/Partnerships

    Please note, in order to apply to any of the Joint Alliance/Partnership programs listed below your organization must also meet Pfizer’s eligibility requirements. Click here to view further details about eligibility.

    • Chronic Pain Associated with Osteoarthritis and Chronic Low Back Pain

      Pfizer and Lilly are working together on grants in support of medical education in chronic pain associated with osteoarthritis and chronic low back pain. We are committed to supporting innovative, independent medical education for healthcare professionals.

      All grant applications should be submitted to Pfizer only, to avoid application duplication. To apply now, go to our grant management system.
    • Diabetes Treatment 

      Pfizer and Merck are working together on grants in support of diabetes treatment-related education. The goal of this education is to increase the understanding of SGLT2 inhibition in the management of diabetes.

      All grant applications should be submitted to Merck only. Please refer to the Merck website for information.
    • Nonsteroidal Anti-Androgen Treatment of Prostate & Breast Cancer

      Pfizer and Astellas are working together on grants in support of prostate cancer-related education. The goal of this education is to increase the ability of healthcare professionals to consistently provide their patients with optimal guidelines-based care.

      Pfizer and Astellas are also invested in advancing the understanding of nonsteroidal anti-androgens in the treatment of breast cancer.

      All grant applications should be submitted to Astellas only. Please refer to the Astellas website for information.
    • Thrombosis Prevention / Anti-coagulation

      Pfizer and Bristol Myers Squibb (BMS) are working together on grants in support of thrombosis / anticoagulation-related education. The goal of this education is to decrease the unmet medical needs in the prevention and treatment of venous and arterial thrombosis.

      All grant applications should be submitted to Bristol Myers Squibb only. Please refer to the Bristol Myers Squibb website for information.